According to FutureWise analysis the market for artificial cardiac valves in 2023 is US$ 8.55 billion, and is expected to reach US$ 20.16 billion by 2031 at a CAGR of 11.32%.
One-way valves are artificial cardiac valves that replace a heart valve that is unhealthy or not working properly (valvular heart disease). There are three broad classes of artificial cardiac valves: mechanical heart valves, bioprosthetic tissue valves, and engineered tissue valves. Damage to heart valves can be caused by birth defects, age-related changes, and other factors, such as rheumatic fever and infections causing endocarditis. A heart attack can lead to scar tissue formation after a high blood pressure condition and heart failure, which can enlarge the heart and arteries.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Artificial Cardiac Valves Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Artificial Cardiac Valves Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.